Big Pharma has a huge appetite to identify and acquire novel treatments .
I remain convinced that Monepantel has intrinsic value which is calculated in the billions. The key question for PAA is how to realise maximum value in bringing our product to a commercial outcome.
Riluzole, the current standard of care for MND has $1bn+ annual sales. With a long patent runway and superior clinical results I expect Monepantel to figure highly on Big Pharma's radar.
Back in May we received the research paper from Prof Fairlie which looked at the anti-tumor activity of Monepantel across multiple human cancer types. It was heavy duty research many years in the making. The implications are mind-blowing.
For anyone who has not viewed the research paper:
https://onlinelibrary.wiley.com/doi/10.1002/cam4.6021
My feeling is that PAA will be targeting Phase 2 Human Cancer clinical trials as soon as finances permit. It has always been the ultimate objective. If a BP want to buy us out early, then I reckon the valuation of Monepantel as a combination therapy for multiple human cancers should be foremost in discussions.
PAA may be a minnow regarding our share price, but we have something of immense value. It may be a little while down the road, but I think we may be setting a new high benchmark in BioTech deals.
My opinion only, Cheers, Thrifty
- Forums
- ASX - By Stock
- FDA Application for Orphan Drug Designation , PAA, MPL
Big Pharma has a huge appetite to identify and acquire novel...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $73.24M |
Open | High | Low | Value | Volume |
18.5¢ | 19.0¢ | 18.3¢ | $334.1K | 1.802M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 111778 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 104266 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 82600 | 0.200 |
3 | 30141 | 0.195 |
1 | 144302 | 0.190 |
2 | 13778 | 0.185 |
12 | 247460 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 109266 | 5 |
0.195 | 806278 | 6 |
0.200 | 132160 | 5 |
0.205 | 93843 | 4 |
0.210 | 51999 | 2 |
Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
Last
18.5¢ |
  |
Change
0.005 ( 2.78 %) |
|||
Open | High | Low | Volume | ||
18.5¢ | 19.0¢ | 18.0¢ | 1184237 | ||
Last updated 15.57pm 16/05/2024 ? |
Featured News
PAA (ASX) Chart |